High D-glucose induces alterations of endothelial cell structure in a cell-culture model

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 2, 1997, Pages 182-190

  Salameh, A ^a   Zinn, M ^a   Dhein, S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Celiprolol; Diabetes mellitus; Endothelium; Glucose; Nitrendipine

Indexed keywords

ACTIN; CELIPROLOL; EOSIN; GLUCOSE; HEMATOXYLIN; NITRENDIPINE; NITROBLUE TETRAZOLIUM; PARAFORMALDEHYDE; PHALLOIDIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GIANT CELL; MULTINUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ACTINS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELIPROLOL; CELLS, CULTURED; COLORING AGENTS; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; GLUCOSE; NADPH DEHYDROGENASE; NITRENDIPINE; OSMOLAR CONCENTRATION; STEREOISOMERISM; SWINE;

EID: 0030862179     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199708000-00006     Document Type: Article

References (32)

1. Kwok CF, Goldstein BJ, Müller-Wieland D, Lee TS, King GL. Identification of persistent defects in insulin receptor structure and function in capillary endothelial cells from diabetic rats. J Clin Invest 1989;83(1):127-36.
2. Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. J Biol Chem 1991;266:14244-50.
3. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced over-expression of basement membrane components in cultured human endothelial cells. Diabetes 1991;49(1):102-10.
4. Hayashi JN, Ito H, Kanayasu T, et al. Effects of glucose on migration, proliferation and tube forming by vascular endothelial cells. Virchows Arch B Cell Pathol 1991;60(4):245-52.
5. Vallance P, Calver A, Collier J. The vascular endothelium in diabetes and hypertension. J Hypertens 1992;10(suppl 1):25-9.
6. Sank A, Wei D, Reid J, et al. Human endothelial cells are defective in diabetic vascular disease. J Surg Res 1994;57:647-53.
7. Busse R, Fleming I, Hecker M. Signal transduction in endothelium-dependent vasodilatation. Eur Heart J 1993;14(suppl 1):2-9.
8. Olbrich A, Rösen P, Dhein S. Fosinopril improves the nitric oxide dependent regulation of the vascular tone in mesenteric bed of diabetic rats. J Cardiovasc Pharmacol 1996;27:187-94.
9. Olbrich A, Rösen P, Klaus W, Dhein S. Effects of celiprolol and metoprolol on diabetic angiopathy in a type I diabetes mellitus rat model [Abstract]. Pharmacol Res 1995;31(suppl):32.
10. Olbrich A, Hardegen P, Rösen P, Klaus W, Dhein S. Antiangiopathic effects of the β-adrenoceptor antagonist celiprolol on rat mesenteric vessels in a type I diabetes model [Abstract]. Naunyn-Schmiedebergs Arch Pharmacol 1995;351(suppl):R117.
11. Tashiro K, Shimokama T, Haraoka S, Tokunaga O, Watanabe T. Endothelial cell heterogeneity in experimentally-induced rabbit atherosclerosis: demonstration of multinucleated giant endothelial cells by scanning electron microscopy and cell culture. Virchows Arch 1994;425:521-9.
12. Antonov AS, Nikolaeva MA, Klueva TS, et al. Primary culture of endothelial cells from atherosclerotic human aorta. Atherosclerosis 1986; 59:1-19.
13. Fleckenstein-Grün G, Thimm F, Czirfuzs A, Matyas S, Frey M. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. J Cardiovasc Pharmacol 1994;24(suppl 2):75-84.
14. Rosenthal AM, Gotlieb AI. Macrovascular endothelial cells from porcine aorta. In: Piper HM, ed. Cell culture techniques in heart and vessel research. Berlin: Springer-Verlag 1990:117-29.
15. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984;99:2034-40.
16. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A 1991;88:2811-4.
17. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci U S A 1979;76:4498-502.
18. Repin VS, Dolgov VV, Zaikina OE, et al. Heterogeneity of endothelium in human aorta. Atherosclerosis 1984;50:35-52.
19. Kuhne W, Besselmann M, Noll T, Muhs A, Watanabe H, Piper P. Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells. Am J Physiol 1993;264:H1599-608.
20. Eder M, Totovic V. Zell- und Gewebsschäden. In: Eder M, Gedigk P, eds. Lehrbuch der allgemeinen Pathologie und der pathologischen Anatomie. Berlin: Springer-Verlag, 1986:6-75.
21. Malik RA, Tesfaye S, Thompson SD, et al. Endoneurinal localisation of microvascular damage in human diabetic neuropathy. Diabetologica 1993;36(5):454-9.
22. Gilcrease MZ, Hoover RL. Neutrophil adhesion to endothelium following hyperosmolar insult. Diabetes Res 1991;16:149-57.
23. Dhein S, Olbrich A, Rösen P, Klaus W. Impairment of NO-dependent regulation of vascular tone in the mesenterium of diabetic rats: influence of a long-term treatment with fosinopril [Abstract]. Naunyn-Schmiedebergs Arch Pharmacol 1994;350(suppl):R15.
24. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991;351:714-8.
25. Enomoto T, Okamoto T, Sato JD. Vascular endothelial growth factor induces the disorganization of actin stress fibres accompanied by protein tyrosine phosphorylation and morphological changes in BALB/c3T3 cells. Biochem Biophys Res Commun 1994;202(3): 1716-23.
26. Goldblum SE, Ding X, Funk SE, Sage H. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barner function. Proc Natl Acad Sci U S A 1994;91:3448-52.
27. DeRuberties FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes: mechanism and potentiation links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994;43 (1):1-8.
28. Olbrich A, Hardegen P, Rösen P, Klaus W, Dhein S. The β-adrenoceptor antagonist celiprolol possesses a protective effect on diabetic mesenteric vessels [Abstract]. Eur J Clin Invest 1995;25(suppl 2):A58.
29. Sung C-P, Eichmann C, Arleth AJ, Truneh A, Ohlstein EH. Carvedilol, a vascular protective agent, inhibits MAP kinase and cell cycle progression in vascular smooth muscle cells [Abstract]. Circulation 1995;(suppl 92)8:I-297.
30. Pieper GM, Dondlinger L. Mechanism for elevated glucose-induced alterations in intracellular calcium signals to bradykinin in cultured endothelial cells [Abstract]. Circulation 1995;92(suppl 8):I-167.
31. Ouchi Y, Orimo H. The role of calcium antagonists in the treatment of atherosclerosis and hypertension. J Cardiovasc Pharmacol 1990;16(suppl 2):1-4.
32. Kazda S. Future prospects for calcium antagonists. Drugs 1994;48 (suppl 1):32-9.